Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a PER.C6® licensing agreement with Upstate USA, Inc., a wholly-owned subsidiary of Serologicals Corporation based in Virginia.
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a PER.C6® licensing agreement with Upstate USA, Inc., a wholly-owned subsidiary of Serologicals Corporation based in Virginia.
